About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Opinion on Drug Safety
›
Top Articles
Expert Opinion on Drug Safety
Pharmacology
4.1
(top 3%)
Impact Factor
4.4
(top 3%)
extended IF
79
(top 5%)
H-Index
1.8K
authors
2K
papers
42.8K
citations
5.7K
citing journals
34.8K
citing authors
Most Cited Articles of Expert Opinion on Drug Safety
Title
Year
Citations
Clinical consequences of polypharmacy in elderly
2014
863
DPP-4 inhibitors: pharmacological differences and their clinical implications
2014
562
Safety of aerosolized amphotericin B
2007
476
Paclitaxel: a review of adverse toxicities and novel delivery strategies
2007
281
An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
2016
253
Long-term side effects of glucocorticoids
2016
249
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
2014
219
A review of the efficacy and safety of oral antidiabetic drugs
2013
205
Drug-induced phospholipidosis: issues and future directions
2006
196
Statin-induced myopathy: a review and update
2011
194
Statin use and cancer risk: a comprehensive review
2010
190
A systematic review of the safety of probiotics
2014
186
Fluoropyrimidine-associated cardiotoxicity: revisited
2009
181
Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity
2005
181
Adverse reactions to first-line antituberculosis drugs
2006
178
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine
2014
177
Renal adverse effects of nonsteroidal anti-inflammatory drugs
2009
169
The role of data mining in pharmacovigilance
2005
169
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
2016
161
A review of existing and emerging digital technologies to combat the global trade in fake medicines
2017
160
Thiazolidinedione safety
2012
159
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms
2006
159
Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety
2006
156
Hydroxychloroquine in systemic lupus erythematosus (SLE)
2017
153
An update on the clinical consequences of polypharmacy in older adults: a narrative review
2018
147
previous
2011
2012
2013
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.